Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Importantly, the 4 mg dose showed a substantially better tolerability profile: its discontinuation rate was 4.1% lower than placebo and it still produced nearly 20% weight loss
Tirzepatide (Zepbound for obesity, Mounjaro for type 2 diabetes) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Measurable weight loss begins within 4 to 8 weeks as the dose increases
Furthermore, patients who drastically reduce caloric intake may experience fatigue and lightheadedness related to inadequate energy substrate availability, even in the absence of frank hypoglycemia
GLP-1 medications work by mimicking the GLP-1 hormone produced by the small intestine that helps trigger insulin release to help manage blood sugar
US$ 25.72
US$ 26.36
US$ 21.33
US$ 20.66
US$ 29.77
US$ 24.18
US$ 23.66
US$ 23.51
US$ 24.14
